Safer Pfizer COVID-19 mRNA Vax Candidate Moves Forward

(MedPage Today) -- With the international collaboration between Pfizer and BioNTech yielding a modified RNA COVID-19 vaccine candidate to progress to phase II/III trials, the manufacturers shared data late Thursday that helped inform the decision...